Navigation Links
Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
Date:6/16/2008

Olympus Corporation to Support the Joint Program through the Provision of

Novel Imaging Systems Collaboration Will Bring Innovative Fluorescent Imaging Agent and System

Technologies into Clinical Trials in Ovarian Cancer

PHILADELPHIA, TOKYO and WOBURN, Mass, June 16 /PRNewswire/ -- Fox Chase Cancer Center and VisEn Medical today announced a partnership to advance Phase I clinical trials of one of VisEn Medical's "smart" fluorescence activatable imaging agents to enable physicians to identify and characterize early stage disease in oncology patients. Olympus Medical Systems Corp. will provide paired fluorescence laparoscopic imaging systems to enable the detection and evaluation of ProSense highlighted tumors in patients in the trials. The clinical trials will initially focus on ovarian cancer and are planned to begin in 2009 at Fox Chase Cancer Center.

Under terms of the program, VisEn will develop and submit an Investigational New Drug (IND) application on a clinical analog of its proprietary fluorescence molecular imaging agent, ProSense(R), which highlights certain enzymatic processes associated with early stage cancer development in vivo. In addition to conducting the clinical trials, Fox Chase Cancer Center will invest in the ProSense clinical program through VisEn and will receive certain rights, equity and royalties on future sales.

"These clinical molecular imaging technologies should provide the foundations for earlier and more accurate disease detection, and more importantly, enhanced functional imaging capabilities that will eventually help guide therapeutic interventions," said Michael V. Seiden, MD, Ph.D., President and CEO of Fox Chase Cancer Center. "Promoting advances in diagnosis that may lead to improved cancer treatments is a key part of Fox Chase's approach to solving the cancer problem, and we are pleased to be working with two of the leaders in molecular imaging to help bring
'/>"/>

SOURCE VisEn Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
2. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
5. New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients
6. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
7. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
8. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
9. Leading Academic Institutions Collaborate on 800-Patient Study of Effectiveness of Cryoablation for Men With Recurrent Prostate Cancer
10. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
11. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ON, Nov. 6 America,s Sp...rking group of mid-market and smaller innovator ph...bout H.R. 3962, the "Affordable Health Care for Am...rsday. These smaller companies fear that the cumu... will hinder their efforts to bring new medicines ...
(Date:11/6/2009)...O, Nov. 6 NuVasive, Inc....d on developing products for minimally disruptive ... the appointment of Michael J. Lambert as Executiv...ctive November 9, 2009. The Company also announce... ,, "Michael will be an excellent complement to...
(Date:11/6/2009)...LLE, Pa., Nov. 6 Philips Respironi... Control and Prevention (CDC) to raise awareness a...leep insufficiency. The CDC,s release of the first...ifferences in sleeplessness is a milestone in quan...As a long-time educator, industry leader and sleep...
Breaking Medicine Technology:Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Our Communities Blood Supply Faces Summer Challenges 48116 1Our Communities Blood Supply Faces Summer Challenges 48116 2Our Communities Blood Supply Faces Summer Challenges 48116 3Integrated Biometrics Adds Security Industry Veteran to Sales Staff 8736 1Integrated Biometrics Adds Security Industry Veteran to Sales Staff 8736 2Latest Developments In Facelift Surgery Expert Opinion by Mr James Murphy 48114 1Latest Developments In Facelift Surgery Expert Opinion by Mr James Murphy 48114 2Latest Developments In Facelift Surgery Expert Opinion by Mr James Murphy 48114 3
..., CAMBRIDGE, Mass. and LONDON, Feb. 6 Idenix Phar...Kline (GSK) today announced the execution of a lic...ghts to IDX899. IDX899 is a novel non-nucleoside ...I clinical development being developed by Idenix f...ed to address the increasing prevalence of viral r...
..., Journal of American College of Cardiology publis...., Feb. 5 Boston Scientific Corporation (NYSE: ... U.S. Food and Drug Administration (FDA) the final...) applications for both its TAXUS(R) Liberte(R) At...d its TAXUS Liberte Long(TM) Paclitaxel-Eluting Co...
Other Medicine Technology:Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 2Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 3Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 4Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 5Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 2Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 3Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 4Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 5
(Date:11/8/2009)... A jury of 8 people in the Wester...woman $2,300,000 in pain and suffering for a medic...mes Tallman and Alicia Nocera of Thomas E. Crenney... the plaintiff, Vita Monestersky and against the U...ency total abdominal hysterectomy at age 18. , ...
(Date:11/8/2009)...ation,s largest network of Hispanic health advocat...eform in 2009 ,, WASHINGTON, Nov. 7 /PRNewswir...entatives showed they have heard the voice of Amer...re for America Act. Now the Senate must deliver, w...care reform," said Dr. Jane L. Delgado, President ...
(Date:11/8/2009)...alls for Swift Passage of H.R. 3961 to Secure the ...wswire-USNewswire/ -- Statement Attributable to: J...Association. ,, (Logo: http://www.newscom.com...hails the passage of the House health reform bill,...ients and physicians and calls for swift passage o...
(Date:11/8/2009)...ealth Care Vote Shows Who Sides With Working Famil..., Nov. 8 On the heels o...esentatives for a good, balanced health care refor...ing of how our state,s U.S. representatives voted ... Act. ,, The legislation, which passed Saturda...
(Date:11/7/2009)...SHINGTON, Nov. 7 Karen ...urance Plans (AHIP), released the following statem...alth plans strongly support comprehensive health c...sion by proposing a complete overhaul of how healt...posed guaranteed coverage, elimination of pre-exis...
Breaking Medicine News(10 mins):Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AHIP Statement on House Passage of H.R. 3962 2
...ns Growthink to Raise $2 Million Dollars in ...S, June 18 Growthink, the leading Investment,Bank...ging and Middle,Market Enterprises, announced toda... by the Food, Beverage,Pharmaceutical and Health S...
...uray,Incorporated (Nasdaq: ARAY ), a global leade...t its president and chief executive officer, Euan ...Jefferies Healthcare,Conference on Thursday, June ...any,s Web site at, http://www.accuray.com . The we...
...itment to Securing Confidential Customer ...SKING RIDGE, N.J. and NEWPORT BEACH, Calif., June ...re technology solutions,serving nearly half of the...ybertrust Enterprise Certification., By meeting t...
... University, Gentag,Inc., and Science Applications...combined forces to develop a non-invasive method f...rs agreed to combine their,respective intellectual...ting products could eliminate the need for finger,...
...e Integrase(TM) assays used to study ... FRANCISCO, Calif., June 18 Monogram,Biosciences,...ompany has,signed an agreement with Gilead Science...tients for study,enrollment and help select drugs ...
...new Lumax 540 technologies together with BIOTRONIK...d patient management that,provides daily protectio... BIOTRONIK GmbH & Co KG, the pioneer in wireless ...es, which,includes implantable cardioverter defibr...
Other Medicine News:Health News:Pop! Technology Goes Growthink 2Health News:Accuray Incorporated's CEO to Speak at Jefferies Second Annual Healthcare Conference 2Health News:TriZetto Maintains Prestigious Verizon Business Security Certification for Sixth Consecutive Year 2Health News:TriZetto Maintains Prestigious Verizon Business Security Certification for Sixth Consecutive Year 3Health News:TriZetto Maintains Prestigious Verizon Business Security Certification for Sixth Consecutive Year 4Health News:No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones 2Health News:No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones 3Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 2Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 3Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 4Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 5Health News:Tomorrow's care today: Lumax 540 cardiac devices launched at Cardiostim 2Health News:Tomorrow's care today: Lumax 540 cardiac devices launched at Cardiostim 3
Dodick-Kammann Nucleus Chopper
Chang Phaco Chopper
Denman Brown Nucleus Cracker
Forceps Epilation Angled End B510.10 3.5"
Medicine Products: